Showing results (601-610 of 615) with videos related to
Sort By:
Pageof 62
Brain Communications|May 24, 2023
Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosisWolfgang P Ruf, Matej Boros, Axel Freischmidt, et al.Annals of Neurology|August 9, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral SclerosisChristina Steffke, Karthik Baskar, Franziska Bachhuber, et al.Biorxiv : the Preprint Server for Biology|August 2, 2024
Transfer RNA acetylation regulates in vivo mammalian stress signalingSupuni Thalalla Gamage, Roxane Khoogar, Shereen Howpay Manage, et al.Nature Neuroscience|March 25, 2015
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementiaAxel Freischmidt, Thomas Wieland, Benjamin Richter, et al.Journal of Affective Disorders|July 13, 2025
Considerations in the development of learning health networks for mood disordersJessica M Lipschitz, Caleb Adler, Jorge Almeida, et al.Eclinicalmedicine|February 22, 2024
Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access programMaximilian Wiesenfarth, Johannes Dorst, David Brenner, et al.Neurological Research and Practice|July 3, 2024
Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre studyKatharina Linse, Constanze Weber, Peter Reilich, et al.Brain : a Journal of Neurology|January 18, 2018
Hot-spot KIF5A mutations cause familial ALSDavid Brenner, Rüstem Yilmaz, Kathrin Müller, et al.The Lancet. Neurology|May 23, 2024
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichael Benatar, Thomas Hansen, Dror Rom, et al.Neurobiology of Aging|May 20, 2014
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival studyPerry T C van Doormaal, Nicola Ticozzi, Cinzia Gellera, et al.Pageof 62